Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (101-110 of 917) with videos related to

Pageof 92
Sort By:
JAMA Network Open|April 3, 2020
Association of Age With Risk of Adverse Pathological Findings at Radical Prostatectomy in Men With Gleason Score 6 Prostate CancerDaniel W Kim, Ming-Hui Chen, Hartwig Huland, et al.
World Journal of Urology|July 25, 2022
Preprostatic lymph nodes in prostate cancer hot or not? Impact on oncological outcome after radical prostatectomyMichael Korten, Randi M Pose, Markus Graefen, et al.
Prostate International|July 1, 2026
Transrectal ultrasound-cystogram versus X-ray-cystogram versus no cystogram: high volume retrospective studyHelene Schuetz, Lukas Hohenhorst, Yamini Nagaraj, et al.
Urologic Oncology|March 20, 2018
Return to work following robot-assisted laparoscopic and open retropubic radical prostatectomy: A single-center cohort study to compare duration of sick leaveStefanie von Mechow, Markus Graefen, Alexander Haese, et al.
Urology|March 13, 2016
The Role of Pelvic Lymph Node Dissection During Radical Prostatectomy in Patients With Gleason 6 Intermediate-risk Prostate CancerPhilipp Mandel, Maximilian C Kriegmair, Valia Veleva, et al.
Urologic Oncology|August 3, 2021
PSMA PET predicts metastasis-free survival in the setting of salvage radiotherapy after radical prostatectomyMike Wenzel, Rada Hussein, Tobias Maurer, et al.
The Journal of Urology|July 20, 2002
Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 testsMartin G Friedrich, Angelika Hellstern, Stefan H Hautmann, et al.
European Urology|May 12, 2012
Prevention and management of postprostatectomy sexual dysfunctions. Part 1: choosing the right patient at the right time for the right surgeryAndrea Salonia, Arthur L Burnett, Markus Graefen, et al.
World Journal of Urology|January 15, 2018
Prostate cancer rates in patients with initially negative elastography-targeted biopsy vs. systematic biopsyJeannette Kratzenberg, Georg Salomon, Pierre Tennstedt, et al.
European Urology|May 12, 2012
Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic functionAndrea Salonia, Arthur L Burnett, Markus Graefen, et al.
Pageof 92

Showing results (101-110 of 917) with videos related to

Sort By:
Pageof 92
JAMA Network Open|April 3, 2020
Association of Age With Risk of Adverse Pathological Findings at Radical Prostatectomy in Men With Gleason Score 6 Prostate CancerDaniel W Kim, Ming-Hui Chen, Hartwig Huland, et al.
World Journal of Urology|July 25, 2022
Preprostatic lymph nodes in prostate cancer hot or not? Impact on oncological outcome after radical prostatectomyMichael Korten, Randi M Pose, Markus Graefen, et al.
Prostate International|July 1, 2026
Transrectal ultrasound-cystogram versus X-ray-cystogram versus no cystogram: high volume retrospective studyHelene Schuetz, Lukas Hohenhorst, Yamini Nagaraj, et al.
Urologic Oncology|March 20, 2018
Return to work following robot-assisted laparoscopic and open retropubic radical prostatectomy: A single-center cohort study to compare duration of sick leaveStefanie von Mechow, Markus Graefen, Alexander Haese, et al.
Urology|March 13, 2016
The Role of Pelvic Lymph Node Dissection During Radical Prostatectomy in Patients With Gleason 6 Intermediate-risk Prostate CancerPhilipp Mandel, Maximilian C Kriegmair, Valia Veleva, et al.
Urologic Oncology|August 3, 2021
PSMA PET predicts metastasis-free survival in the setting of salvage radiotherapy after radical prostatectomyMike Wenzel, Rada Hussein, Tobias Maurer, et al.
The Journal of Urology|July 20, 2002
Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 testsMartin G Friedrich, Angelika Hellstern, Stefan H Hautmann, et al.
European Urology|May 12, 2012
Prevention and management of postprostatectomy sexual dysfunctions. Part 1: choosing the right patient at the right time for the right surgeryAndrea Salonia, Arthur L Burnett, Markus Graefen, et al.
World Journal of Urology|January 15, 2018
Prostate cancer rates in patients with initially negative elastography-targeted biopsy vs. systematic biopsyJeannette Kratzenberg, Georg Salomon, Pierre Tennstedt, et al.
European Urology|May 12, 2012
Prevention and management of postprostatectomy sexual dysfunctions part 2: recovery and preservation of erectile function, sexual desire, and orgasmic functionAndrea Salonia, Arthur L Burnett, Markus Graefen, et al.
Pageof 92